Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylometazoline versus placebo after CPAP withdrawal in mild to moderate obstructive sleep apnoea
2018-000065-37Phase 3Suspended
- Sponsor
- University of Oxford
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Xylometazoline with Placebo (2 arms). Started Dec 2018; status: suspended.
02
Drugs
xylometazoline
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2018-000065-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000065-37.